Monitoring autoimmune reactivity within the retina

Manual of Molecular and Clinical Laboratory Immunology: 7th edition

Volumn , Issue , 2022, Pages 1136-1140

  Hooks, John J ^a   Chin, Marian S ^a   Chan, Chi Chao ^a   Detrick, Barbara ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretinal immune reactivity; Cancer associated retinopathy (CAR); Retinal diseases; Retinal pigment epithelium (RPE)

Indexed keywords

EID: 85182965059     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555815905.ch129     Document Type: Chapter

References (24)

1. Adamus, G., M. Machnicki, H. Elerding, B. Sugden, Y. S. Blocker, and D. A. Fox. 1998. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J. Autoimmun. 11:523-533.
2. Braun, G., N. M. McKechnie, and W. Gurr. 1995. Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus. J. Exp. Med. 182:1121-1131.
3. Cassoux, N., H. Merle-Beral, P. Lehoang, C. Herbort, and C. C. Chan. 2001. Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 108:426-427.
4. Chan, C. C., and M. Mochizuki. 1999. Sympathetic ophthalmia: an autoimmune ocular inflammatory disease. Springer Semin. Immunopathol. 21:125-134.
5. Chan, C. C., R. B. Nussenblatt, L. S. Fujikawa, A. G. Palestine, G. Stevens, Jr., L. M. Parver, M. W. Luckenbach, and T. Kuwabara. 1986. Sympathetic ophthalmia. Immunopathological findings. Ophthalmology 93:690-695.
6. Chan, C. C., R. B. Nussenblatt, M. K. Kim, A. G. Palestine, K. Awadzi, and E. A. Ottesen. 1987. Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology 94:439-443.
7. Chan, C. C., and D. J. Wallace. 2004. Intraocular lymphoma: update on diagnosis and management. Cancer Control 11:285-295.
8. Chan, C. C., S. M. Whitcup, D. Solomon, and R. B. Nussenblatt. 1995. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am. J. Ophthalmol. 120:671-673.
9. Hooks, J. J., B. Detrick, and R. Nussenblatt. 2004. Infections associated with retinal autoimmunity, p. 691-700. In Y. Shoenfeld and N. R. Rose (ed.), Infection and Autoimmunity. Elsevier, Amsterdam, The Netherlands.
10. Hooks, J. J., M. O. Tso, and B. Detrick. 2001. Retinopathies associated with antiretinal antibodies. Clin. Diagn. Lab. Immunol. 8:853-858.
11. Hormigo, A., L. Abrey, M. H. Heinemann, and L. M. DeAngelis. 2004. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br. J. Haematol. 126:202-208.
12. Lei, B., R. A. Bush, A. H. Milam, and P. A. Sieving. 2000. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Investig. Ophthalmol. Vis. Sci. 41:262-266.
13. McKechnie, N. M., W. Gurr, and G. Braun. 1997. Immunization with the cross-reactive antigens Ov39 from Onchocerca volvulus and hr44 from human retinal tissue induces ocular pathology and activates retinal microglia. J. Infect. Dis. 176:1334-1343.
14. Milam, A. H., J. C. Saari, S. G. Jacobson, W. P. Lubiński, L. G. Feun, and K. R. Alexander. 1993. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest. Ophthalmol. Vis. Sci. 34:91-100.
15. Murphy, M. A., C. E. Thirkill, and W. M. Hart, Jr. 1997. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. J. Neuroophthalmol. 17:77-83.
16. Nussenblatt, R. B., I. Gery, E. J. Ballintine, and W. B. Wacker. 1980. Cellular immune responsiveness of uveitis patients to retinal S-antigen. Am. J. Ophthalmol. 89:173-179.
17. Nussenblatt, R. B., and S. M. Whitcup. 2003. Uveitis: Fundamentals and Clinical Practice, 3rd ed. Mosby, Philadelphia, Pa.
18. Resnikoff, S., D. Pascolini, D. Etya'ale, I. Kocur, R. Pararajasegaram, G. P. Pokharel, and S. P. Mariotti. 2004. Global data on visual impairment in the year 2002. Bull. WH. O. 82:844-851.
19. Sawyer, R. A., J. B. Selhorst, L. E. Zimmerman, and W. F. Hoyt. 1976. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am. J. Ophthalmol. 81:606-613.
20. Tan, E. M., T. E. Feltkamp, J. S. Smolen, B. Butcher, R. Dawkins, M. J. Fritzler, T. Gordon, J. A. Hardin, J. R. Kalden, R. G. Lahita, R. N. Maini, J. S. McDougal, N. F. Rothfield, R. J. Smeenk, Y. Takasaki, A. Wiik, M. R. Wilson, and J. A. Koziol. 1997. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 40:1601-1611.
21. Thirkill, C. E., P. FitzGerald, R. C. Sergott, A. M. Roth, N. K. Tyler, and J. L. Keltner. 1989. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N. Engl. J. Med. 321:1589-1594.
22. Whitcup, S. M., V. Stark-Vancs, R. E. Wittes, D. Solomon, M. J. Podgor, R. B. Nussenblatt, and C. C. Chan. 1997. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch. Ophthalmol. 115:1157-1160.
23. Whittle, R. M., G. R. Wallace, R. A. Whiston, D. C. Dumonde, and M. R. Stanford. 1998. Human antiretinal antibodies in toxoplasma retinochoroiditis. Br. J. Ophthalmol. 82:1017-1021.
24. Wolf, L. A., G. F. Reed, R. R. Buggage, R. B. Nussenblatt, and C. C. Chan. 2003. Vitreous cytokine levels. Ophthalmology 110:1671-1672.